Life sciences · Observational Study
ClinicalTrials.gov · September 22, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Observational Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07833566). This is a study registration, not published results. Lead sponsor: University of Oklahoma. Recruitment status: RECRUITING. Study type: OBSERVATIONAL. Enrollment: 140 participants (ESTIMATED). Conditions: Breast Cancer. Interventions: DEVICE: Biopsy-Site Marker Placement.. Primary outcome measures: Proportion of Patients With Evaluable Tissue Samples. , 1 year; Differences in Stiffness of Tissue Samples Collected During Surgical Biopsy. , 1 Year. Brief summary: The purpose of this study is to explore pro-metastatic changes in breast cancer (BC) associated with the stiffness of biopsy site markers. This study aims to determine whether the stiffness of a biopsy site marker promotes inflammatory changes in breast cancer and to evaluate whether there is a relationship between biopsy site marker stiffness and inflammation.